Literature DB >> 21441825

Recent insights into the relationship between inflammatory liver diseases and atherosclerosis.

Tugrul Purnak1, Cumali Efe, Yavuz Beyazit, Ersan Ozaslan, Ramazan Astan, Aysel Milanloglu, Zeynep Ozbalkan, Manfredi Rizzo.   

Abstract

Atherosclerosis is a dynamic process in the human body. Many studies have evaluated atherosclerosis and its relationship with other systems in the body. Our perception of its pathogenesis is evolving with the introduction of new players in the game. It is no longer possible to consider the atherosclerosis as an independent process, unaffected by the liver and its function. Although several tasks performed by the liver, such as lipid metabolism, have been implicated in the pathogenesis of atherosclerosis, the role of other disorders of the liver (autoimmune diseases, viral hepatitis, and cirrhosis) are not fully understood. In this review, the most commonly encountered inflammatory liver diseases and their effects on atherosclerosis are discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21441825     DOI: 10.2310/JIM.0b013e318217f3a0

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  4 in total

Review 1.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Sexually Dimorphic Relationships Among Saa3 (Serum Amyloid A3), Inflammation, and Cholesterol Metabolism Modulate Atherosclerosis in Mice.

Authors:  Alan Chait; Shari Wang; Leela Goodspeed; Diego Gomes; Katherine E Turk; Tomasz Wietecha; Jingjing Tang; Carl Storey; Kevin D O'Brien; Katya B Rubinow; Chongren Tang; Tomas Vaisar; Sina A Gharib; Aldons J Lusis; Laura J Den Hartigh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-25       Impact factor: 10.514

3.  HCV, but not HIV, is a risk factor for cerebral small vessel disease.

Authors:  Susan Morgello; Jacinta Murray; Sarah Van Der Elst; Desiree Byrd
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-09-04

4.  Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR-/- Mice.

Authors:  Yifan Zhang; Min Du; Jiarou Wang; Ping Liu
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.